idecabtagene vicleucel
bms,2seventy bio
['ide-cel', 'karmma', 'abecma']
#ash22
christopher ferreri from discusses the tolerability of ide-cel for patients with rrmm and outcomes with prior therapy 
The Multiple Myeloma (MM) Hub is an online educational resource run in collaboration with the European School of Haematology @ESHaematology #mmsm #myeloma